Dr James Andrew Legako, DO | |
1303 Sw First American Place, Topeka, KS 66604-4040 | |
(785) 234-2306 | |
(785) 234-2550 |
Full Name | Dr James Andrew Legako |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 18 Years |
Location | 1303 Sw First American Place, Topeka, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578731535 | NPI | - | NPPES |
200733350A | Medicaid | KS | |
1578731535 | Other | KS | BCBS |
Facility Name | Location | Facility Type |
---|---|---|
Newman Regional Health | Emporia, KS | Hospital |
Stormont Vail Hospital | Topeka, KS | Hospital |
St Luke Hospital & Living Center | Marion, KS | Hospital |
Hillsboro Community Hospital | Hillsboro, KS | Hospital |
University Of Kansas Health System - St Francis Campus | Topeka, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Radiology And Nuclear Medicine Llc | 3274425772 | 27 |
News Archive
Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.
When clinical trials were conducted to determine the immunogenicity - the ability to elicit an immune response - for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.
A systematic review and meta-analysis from the Regenstrief Institute and Indiana University School of Medicine has found that, in spite of the higher incidence and death rate of colorectal cancer in blacks, no difference exists in the overall prevalence of advanced, precancerous polyps between average-risk blacks and whites who underwent a screening colonoscopy.
Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.
Acurian, a leader in clinical trial patient recruitment and retention, announced today that its opted-in patient database is an effective resource for reaching minority populations for patient recruitment. Increasing minority participation is crucial for trial success and regulatory approval, especially for therapies intended to treat diseases with high incidence and prevalence rates among minorities.
› Verified 7 days ago
Entity Name | Cotton O'neil Clinic Revocable Trust |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.
When clinical trials were conducted to determine the immunogenicity - the ability to elicit an immune response - for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.
A systematic review and meta-analysis from the Regenstrief Institute and Indiana University School of Medicine has found that, in spite of the higher incidence and death rate of colorectal cancer in blacks, no difference exists in the overall prevalence of advanced, precancerous polyps between average-risk blacks and whites who underwent a screening colonoscopy.
Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.
Acurian, a leader in clinical trial patient recruitment and retention, announced today that its opted-in patient database is an effective resource for reaching minority populations for patient recruitment. Increasing minority participation is crucial for trial success and regulatory approval, especially for therapies intended to treat diseases with high incidence and prevalence rates among minorities.
› Verified 7 days ago
Entity Name | Radiology And Nuclear Medicine Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699733162 PECOS PAC ID: 3274425772 Enrollment ID: O20040329000886 |
News Archive
Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.
When clinical trials were conducted to determine the immunogenicity - the ability to elicit an immune response - for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.
A systematic review and meta-analysis from the Regenstrief Institute and Indiana University School of Medicine has found that, in spite of the higher incidence and death rate of colorectal cancer in blacks, no difference exists in the overall prevalence of advanced, precancerous polyps between average-risk blacks and whites who underwent a screening colonoscopy.
Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.
Acurian, a leader in clinical trial patient recruitment and retention, announced today that its opted-in patient database is an effective resource for reaching minority populations for patient recruitment. Increasing minority participation is crucial for trial success and regulatory approval, especially for therapies intended to treat diseases with high incidence and prevalence rates among minorities.
› Verified 7 days ago
Entity Name | Clearview Imaging Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790303550 PECOS PAC ID: 6507240090 Enrollment ID: O20220901001321 |
News Archive
Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.
When clinical trials were conducted to determine the immunogenicity - the ability to elicit an immune response - for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.
A systematic review and meta-analysis from the Regenstrief Institute and Indiana University School of Medicine has found that, in spite of the higher incidence and death rate of colorectal cancer in blacks, no difference exists in the overall prevalence of advanced, precancerous polyps between average-risk blacks and whites who underwent a screening colonoscopy.
Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.
Acurian, a leader in clinical trial patient recruitment and retention, announced today that its opted-in patient database is an effective resource for reaching minority populations for patient recruitment. Increasing minority participation is crucial for trial success and regulatory approval, especially for therapies intended to treat diseases with high incidence and prevalence rates among minorities.
› Verified 7 days ago
Entity Name | Interventional Pain Group Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558989277 PECOS PAC ID: 2567846975 Enrollment ID: O20220902002724 |
News Archive
Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.
When clinical trials were conducted to determine the immunogenicity - the ability to elicit an immune response - for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.
A systematic review and meta-analysis from the Regenstrief Institute and Indiana University School of Medicine has found that, in spite of the higher incidence and death rate of colorectal cancer in blacks, no difference exists in the overall prevalence of advanced, precancerous polyps between average-risk blacks and whites who underwent a screening colonoscopy.
Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.
Acurian, a leader in clinical trial patient recruitment and retention, announced today that its opted-in patient database is an effective resource for reaching minority populations for patient recruitment. Increasing minority participation is crucial for trial success and regulatory approval, especially for therapies intended to treat diseases with high incidence and prevalence rates among minorities.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James Andrew Legako, DO 1303 Sw First American Place, Topeka, KS 66604-4040 Ph: (785) 234-2306 | Dr James Andrew Legako, DO 1303 Sw First American Place, Topeka, KS 66604-4040 Ph: (785) 234-2306 |
News Archive
Filial piety - the traditional value of caring for one's elders - is foundational to the Chinese concept of family and greatly influences intergenerational relationships.
When clinical trials were conducted to determine the immunogenicity - the ability to elicit an immune response - for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.
A systematic review and meta-analysis from the Regenstrief Institute and Indiana University School of Medicine has found that, in spite of the higher incidence and death rate of colorectal cancer in blacks, no difference exists in the overall prevalence of advanced, precancerous polyps between average-risk blacks and whites who underwent a screening colonoscopy.
Mosquitoes are known to be vectors or bearers of several viral and protozoal infections such as dengue, Zika, yellow fever, Chikungunya, and malaria. These infections are known to infect and even kill millions around the world each year. In order to tackle this vector-borne menace, researchers have genetically engineered mosquitoes that could replace the infection carrying species of the mosquitoes.
Acurian, a leader in clinical trial patient recruitment and retention, announced today that its opted-in patient database is an effective resource for reaching minority populations for patient recruitment. Increasing minority participation is crucial for trial success and regulatory approval, especially for therapies intended to treat diseases with high incidence and prevalence rates among minorities.
› Verified 7 days ago
Dr. Patrick James Landes, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1303 Sw First American Pl, Topeka, KS 66604 Phone: 785-234-2306 Fax: 785-234-2550 | |
Dr. Brett Troy Meggison, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1303 Sw First American Pl, Topeka, KS 66604 Phone: 785-234-2306 Fax: 785-234-2550 | |
John K Ma, MD, PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1414 Sw 8th Ave, Topeka, KS 66606 Phone: 785-354-5300 | |
Dr. Frederick Sauter Neuer, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1303 Sw First American Pl, Topeka, KS 66604 Phone: 785-234-2306 Fax: 785-234-2550 | |
Dr. James Wilson Owen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1303 Sw First American Pl, Topeka, KS 66604 Phone: 785-234-2306 Fax: 785-234-2550 | |
Dr. Richard Marc Schworm, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1303 Sw First American Pl, Topeka, KS 66604 Phone: 785-234-2306 Fax: 785-234-2550 | |
Dr. Marlin J Fugate, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1303 Sw First American Pl, Topeka, KS 66604 Phone: 785-234-2306 Fax: 785-234-2550 |